Browsing by Author "Yang, James Chih-Hsin"
Now showing items 1-3 of 3
-
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
Yang, James Chih-Hsin; Jänne, Pasi A.; Ramalingam, Suresh; Kim, Tae Min; Riely, Gregory; FELIP, ENRIQUETA; Zhou, Caicun (Taylor & Francis, 2023) -
HERTHENA-Lung01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated metastatic EGFR-mutated NSCLC
Yu, Helena A; Hayashi, Hidetoshi; Goto, Yasushi; Reck, Martin; Yang, James Chih-Hsin; FELIP, ENRIQUETA (Future Medicine, 2023-06) -
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC
Levy, Benjamin; Cappuzzo, Federico; Yoneshima, Yasuto; Reck, Martin; Yang, James Chih-Hsin; FELIP, ENRIQUETA (Future Medicine, 2023-07)